QualityStocks Stock Newsletters Archives - Page 1140 of 1818

FridayFeb 15, 2008 5:55 am

NASDAQ Listing and Emerging Market Business Make a Winning Combination of Sorl Auto Parts Inc. (SORL) Stock

Automobiles heralded the stock market age in North America. Detroit has been an enduring symbol of private enterprise backed democratically by public contributions to equity. We do not know if the migration of these industrial and financial powers to emerging economies and to other lands is permanent, but stock investment in road transportation of goods and people remains an important component of the most stable investment portfolios. Here is a stock that gives American stock investors a rare chance to own stocks of a sizeable and reasonably profitable auto and truck parts industry player from China. The stock listing on…

FridayFeb 15, 2008 5:54 am

AngioDynamics Inc. (ANGO) Business Improves Quality of Life for Older People

It is significant that the stock has earned a net profit for the most recent quarter (ended November 2007) because the healthcare sector is so full of small capital securities with good ideas but negative operating margins. The Medical Equipment and Supplies industry depends on physician and surgeon endorsements, and there are signs that the medical community does indeed find this company’s minimally invasive and image-guided products useful. Peripheral Vascular Disease (PVD) is a nearly inseparable part of rising longevity in the population at large, but modern lifestyles increase chances of small blood vessels hardening and narrowing. The company is…

FridayFeb 15, 2008 5:54 am

Heelys Inc. (HLYS) Management in Tune with Youth

The simple pleasure of a quick and unobtrusive shift from walking on the street to skating, or even to gliding over a railing is hardly likely to appeal to a serious stock investor. However, it is a profitable business with almost unlimited growth potential. Why does putting wheels on footwear make such good business sense? The art of branding is taught extensively in business management schools, but true successes are rare. Niches have natural growth limits, while a poorly defined customer segment can reduce a proprietary business to the generic level of profitability. This stock is an excellent example of…

ThursdayFeb 14, 2008 5:31 pm

Everybody Loves Uno

It’s not hard to find love on Valentine’s Day, even in the investing world, though sometimes it’s easy to feel unloved by the markets, particularly by the stocks we trade or invest in. But we all like a feel-good story, so how about this for a segue? Uno the Beagle won the Best in Show at the Westminster Kennel Club just concluded on Wednesday. What’s the big deal, you ask? Well, if you’ve seen Uno, he’s quite a precocious charming lad of three years old, and in a sporting upset, he downed all other dogs for a first, a beagle…

ThursdayFeb 14, 2008 5:27 pm

Nothing Abstract About Concrete

Some traders are great at making super-fast plays on esoteric industries, some of which may not even have products and earnings yet. Others like to wait a bit and see how things shape up, then decide to jump in, while still others like to trade large cap or mid-cap stocks when there’s some big news, with either a surge or a sharp drop in price. Then there are some long-term buy-and-hold investors for whom the dullest of companies in the dullest of industries, companies who make something so tangible you can go see it, touch it, feel it, and for…

ThursdayFeb 14, 2008 5:23 pm

CEL-SCI Corporation’s (CVM) Multikine® Product First Comprehensive Immunotherapy Treatment for Cancer

CEL-SCI Corporation (CVM.AMEX) is a biotechnology company involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. Multikine®, the company’s flagship cancer product, will begin global Phase III clinical trial in 2008. Multikine® is the first immunotherapeutic agent being tested as a first-line standard of care cancer treatment. Multikine® is a non-traditional approach to cancer treatment that utilizes the body’s natural ability to fight tumors. Multikine® is also the first of a new class of cancer immunotherapy drugs. It is the first comprehensive immunotherapy and the first immune simulator. This product is unique…

ThursdayFeb 14, 2008 10:49 am

Amish Naturals, Inc. (AMNT.OB) Expands Distribution Online and Major Retail Stores

Today many people are concerned with the quality of the food they eat. More and more products today are creating many woes for health conscious people who want to make sure the products they consume are all natural. Therefore, organic food was developed to ensure that people could trust the food they were eating was grown under the most healthful and natural conditions. Last year, the U.S. market for natural and organic food was estimated to have totaled over $13 billion. As the demands for organic foods grows, many companies like Amish Naturals is looking to find their share in…

ThursdayFeb 14, 2008 8:52 am

OTCReporter Featured Company: Xynergy Corporation (XYNG.PK) Announced Acquisition of Prototype Air Conditioning System

Xynergy Corporation (OTC:XYNG.PK) announced today that it has acquired the intellectual property, marketing and patent rights for a revolutionary prototype air conditioning system. The system eliminates the need for specialty technical service, doesn't require gas for operation, reduces energy consumption by 30%, and takes up less physical space. The signing of the deal took place yesterday afternoon, and grants Xynergy 100% of all rights. The negotiations have been going on for the past several months, and gave the inventor a significant equity stake in the company, but the terms of the deal have not been disclosed. The Company expects to…

ThursdayFeb 14, 2008 7:29 am

ExpressIR Inc. Provides Top Quality Investor Relations Services

ExpressIR Inc. (EIR) is a national investor relations firm founded by experienced professionals in the fields of investor relations and financial analysis. The company is focused on educating investors about the companies it represents, and does so by providing comprehensive, customized investor relations services to small and medium-sized public companies. EIR focuses on building a strong relationship with its readers, subscribers and investors in order to gain trust and be able to clearly communicate its message about the clients it represents. They supply helpful links to relevant sites and keep all press releases relating to their clients updated on a…

ThursdayFeb 14, 2008 5:02 am

Universal Travel Group (UTVG.OB) Has a Business Management Text Book Net revenue Model in Place

The stock is certain to catch the attention of every OTC market observer. It is a nearly ideal case of a Los Angeles company operating in Mainland China. The management has earned nearly an 18% net profit margin over the last four quarters and a 72% return on average equity. The stock traded at $2.74 on February 13 2008 against a 52-week low of just $0.75. Obviously, the business deserves a close look. China business and leisure travel is a wonderful profit formula. It is possible to discern a sequence of management moves that give the company multiple choices in…

Site Search

Company Search

Category: QualityStocks Stock Newsletters